SPRY Long Call Strategy
SPRY (ARS Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
SPRY (ARS Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $600.8M, a beta of 0.88 versus the broader market, a 52-week range of 4.91-16.65, average daily share volume of 1.9M, a public-listing history dating back to 2020, approximately 157 full-time employees. These structural characteristics shape how SPRY stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.88 places SPRY roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long call on SPRY?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
SPRY snapshot
As of August 14, 2026, spot at $5.58, ATM IV 379.40%, IV rank 80.19%, expected move 108.77%. The long call on SPRY below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long call structure on SPRY specifically: SPRY IV at 379.40% is rich versus its 1-year range, which makes a premium-buying SPRY long call relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 108.77% (roughly $6.07 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SPRY expiries trade a higher absolute premium for lower per-day decay. Position sizing on SPRY should anchor to the underlying notional of $5.58 per share and to the trader's directional view on SPRY stock.
SPRY long call setup
The SPRY long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SPRY at $5.58 on that close, the first option leg uses a $5.58 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SPRY chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SPRY shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $5.58 | N/A |
SPRY long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
SPRY long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on SPRY. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on SPRY
Long calls on SPRY express a bullish thesis with defined risk; traders use them ahead of SPRY catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
SPRY thesis for this long call
The market-implied 1-standard-deviation range for SPRY extends from approximately $-0.49 on the downside to $11.65 on the upside. A SPRY long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current SPRY IV rank near 80.19% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on SPRY at 379.40%. As a Healthcare name, SPRY options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SPRY-specific events.
SPRY long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SPRY positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SPRY alongside the broader basket even when SPRY-specific fundamentals are unchanged. Long-premium structures like a long call on SPRY are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current SPRY chain quotes before placing a trade.
Frequently asked questions
- What is a long call on SPRY?
- A long call on SPRY is the long call strategy applied to SPRY (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With SPRY stock at $5.58 on the most recent close, the strikes shown on this page are snapped to the nearest listed SPRY chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are SPRY long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the SPRY long call priced from the end-of-day chain at a 30-day expiry (ATM IV 379.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SPRY long call?
- The breakeven for the SPRY long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The SPRY market-implied 1-standard-deviation expected move in the same options snapshot is approximately 108.77%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on SPRY?
- Long calls on SPRY express a bullish thesis with defined risk; traders use them ahead of SPRY catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current SPRY implied volatility affect this long call?
- SPRY ATM IV is at 379.40% with IV rank near 80.19%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.